Occlusion device
US-9668742-B2 · Jun 6, 2017 · US
US10076406B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10076406-B2 |
| Application number | US-201514979770-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 28, 2015 |
| Priority date | Dec 31, 2014 |
| Publication date | Sep 18, 2018 |
| Grant date | Sep 18, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An endoluminal prosthesis for placement within a body vessel may include a tubular support structure including a proximal end segment, a distal end segment, an intermediate segment positioned between the proximal end segment and the distal end segment, a lumen extending longitudinally within the support structure, a luminal surface, and an abluminal surface opposite the luminal surface. The prosthesis may include a first layer of nonwoven electrospun fibers positioned on the luminal surface of the support structure. The prosthesis may include a second layer of nonwoven electrospun fibers positioned on the abluminal surface of the support structure. At least one of the proximal end segment or the distal end segment of the support structure may be encapsulated within a covering including the first layer of nonwoven electrospun fibers and the second layer of nonwoven electrospun fibers. The intermediate segment of the support structure may be unencapsulated within the covering.
Opening claim text (preview).
What is claimed is: 1. A medical device for treating a body vessel, comprising: a tubular support structure having a lumen extending longitudinally through the tubular support structure, a luminal surface, and an abluminal surface opposite the luminal surface; a first sol-gel layer disposed at least partially on the luminal surface of the tubular support structure; at least one first non-woven layer of polymeric fibers disposed at least partially over the first sol-gel layer; and at least one second non-woven layer of polymeric fibers disposed at least partially on the abluminal surface of the tubular support structure, wherein the first sol-gel layer comprises TiO 2 and SiO 2 and wherein the ratio of TiO 2 and SiO 2 is from 11:1 TiO 2 :SiO 2 to 7:1 TiO 2 :SiO 2 . 2. The medical device of claim 1 , wherein the first sol-gel layer has a ratio of 9 to 1 TiO 2 :SiO 2 . 3. The medical device of claim 1 , wherein the first sol-gel layer has a ratio of 8 to 1 TiO 2 :SiO 2 . 4. The medical device of claim 1 , wherein the first sol-gel layer consists essentially of TiO 2 and SiO 2 . 5. The medical device of claim 1 , wherein fibers of the polymeric fibers sheets are selected from the group consisting of poly(urethanes), poly(siloxanes), silicones, poly(ethylene), poly(vinyl pyrrolidone), polyethylene terephthalate, poly(2-hydroxy ethyl methacrylate), poly(N-vinyl pyrrolidone), poly(methyl methacrylate), poly(vinyl alcohol), poly(acrylic acid), polyacrylamide, poly(ethylene-co-vinyl acetate), poly(ethylene glycol), poly(methacrylic acid), polylactides (PLA), polyglycolides (PGA), poly(lactide-co-glycolides) (PLGA), polyanhydrides, polytetrafluoroethylene (PTFE), polyorthoesters, and combinations thereof. 6. The medical device of claim 1 , wherein the polymeric fibers are selected from the group consisting of polyethylene terephthalate, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), and mixtures thereof. 7. The medical device of claim 1 , wherein the medical device further comprises a second sol-gel layer coated at least partially on the abluminal surface of the tubular support structure. 8. The medical device of claim 7 , wherein the second sol-gel layer is selected from the group consisting of TiO 2 , Al 2 O 3 , ZrO 2 , CeO 2 , Fe 2 O 3 , BaTiO 3 , MgO, SnO 2 , B 2 O 3 , P 2 O 5 , PbO, silicon dioxide, indium-tin-oxide, fluorine-doped tin oxide, antimony-doped tin oxide, zinc oxide, aluminum-zinc-oxide, and fluorine-zinc-oxide. 9. The medical device of claim 8 , wherein the second sol-gel layer comprises silicon dioxide. 10. A medical device comprising: a support structure having a lumen extending longitudinally through the support structure, a luminal surface, and an abluminal surface opposite the luminal surface; a first sol-gel layer on the luminal surface of the support structure and a second sol-gel layer on the abluminal surface of the support structure wherein the first sol-gel layer consists essentially of TiO 2 and SiO 2 in a ratio from 11:1 TiO 2 :SiO 2 to 7:1 TiO 2 :SiO 2 ; a first sheet of non-woven polymeric fibers disposed at least partially over the first sol-gel layer on the luminal surface of the support structure; and a second sheet of non-woven polymeric fibers disposed at least partially over the second sol-gel layer on the abluminal surface of the support structure. 11. The medical device of claim 10 , wherein the fiber sheets comprise nanofibers or microfibers of polyethylene terephthalate. 12. The medical device of claim 10 , wherein the ratio of TiO 2 and SiO 2 is from 9 to 1 TiO 2 :SiO 2 and the second sol-gel layer comprises silicon dioxide. 13. A medical device for treating a medical device, the medical device comprising: a support structure comprising a lumen extending longitudinally through the support structure, a luminal surface, and an abluminal surface opposite the luminal surface; a first sol-gel layer on the luminal surface of the support structure and a second sol-gel layer on the abluminal surface of the support structure, the first sol-gel layer consists essentially of TiO 2 and SiO 2 in a ratio of from 11:1 TiO 2 :SiO 2 to 7:1 TiO 2 :SiO 2 ; a first non-woven layer of polymeric fibers disposed at least partially over the first sol-gel layer on the luminal surface of the support structure; and a second non-woven layer of polymeric fibers disposed at least partially over the second sol-gel layer on the abluminal surface of the support structure. 14. The medical device of claim 13 , wherein the second sol-gel layer is disposed at least partially on both of the luminal surface and the abluminal surface of the tubular support structure such that a portion of the second sol-gel layer is in contact with the first sol-gel layer and the second non-woven layer of polymeric fibers. 15. The medical device of claim 14 , wherein the second sol-gel layer comprises silicon dioxide. 16. A medical device for treating a body vessel, comprising: a tubular support structure having a lumen extending longitudinally through the tubular support structure, a luminal surface, and an abluminal surface opposite the luminal surface; a first sol-gel layer disposed at least partially on the luminal surface of the tubular support structure; at least one first non-woven layer of polymeric fibers disposed at least partially over the first sol-gel layer; and at least one second non-woven layer of polymeric fibers disposed at least partially on the abluminal surface of the tubular support structure, wherein the first sol-gel layer consists essentially of TiO 2 and SiO 2 in a ratio of 9 to 1 TiO 2 :SiO 2 . 17. A medical device for treating a body vessel, comprising: a tubular support structure having a lumen extending longitudinally through the tubular support structure, a luminal surface, and an abluminal surface opposite the luminal surface; a first sol-gel layer disposed at least partially on the luminal surface of the tubular support structure; a second sol-gel layer coated at least partially on the abluminal surface of the tubular support structure at least one first non-woven layer of polymeric fibers disposed at least partially over the first sol-gel layer; and at least one second non-woven layer of polymeric fibers disposed at least partially on the abluminal surface of the tubular support structure, wherein the first sol-gel layer comprises TiO 2 and SiO 2 in a ratio of 9 to 1 TiO 2 :SiO 2 and the second sol-gel layer comprises silicon dioxide. 18. A medical device for treating a body vessel, comprising: a tubular support structure having a lumen extending longitudinally through the tubular support structure, a luminal surface, and an abluminal surface opposite the luminal surface; a first sol-gel layer disposed at least partially on the luminal surface of the tubular support structure; a second sol-gel layer coated at least partially on the abluminal surface of the tubular support structure at least one first non-woven layer of polymeric fibers disposed at least partially over the first sol-gel layer; and at least one second non-woven layer of polymeric fibers disposed at least partially on the abluminal surface of the tubular support structure, wherein the first sol-gel layer consists essentially of TiO 2 and SiO 2 in a ratio of 9 to 1 TiO 2 :SiO 2 and the second sol-gel layer comprises silicon dioxide.
Other specific inorganic materials not covered by A61L31/084 or A61L31/086 · CPC title
the wire-like elements comprising two or more adjacent rings flexibly connected by separate members · CPC title
Macromolecular materials · CPC title
Layered products · CPC title
Operations & Transport · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.